There were 2,465 press releases posted in the last 24 hours and 441,528 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Genmab Announces Ofatumumab Phase III Study in Follicular Lymphoma to be Stopped Following Planned Interim Analysis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image